Shu Kasama
Papers
1
Total Citations
5
H-Index
1
About
Shu Kasama is a clinical researcher advancing perioperative medicine, with a focus on nociception monitoring and opioid-sparing analgesic strategies. Their key research area centers on the nociception level (NOL) index—a real-time measure of noxious stimulus response during surgery. Kasama’s major contribution is the NOLDOR trial, a single-centre, single-blinded randomized controlled study investigating whether NOL-directed analgesic management can reduce opioid usage in robot-assisted laparoscopic radical prostatectomy. This work addresses a critical challenge: balancing adequate pain control with minimizing opioid-related side effects. While the protocol paper has garnered 5 citations, its significance lies in addressing a controversial finding—that NOL guidance might inadvertently increase opioid administration—by rigorously testing its clinical utility. Kasama’s research bridges anesthesiology and urologic surgery, offering a data-driven path toward personalized, safer perioperative care. Their efforts contribute to the growing evidence base for closed-loop analgesic systems, potentially transforming how clinicians manage nociception during minimally invasive procedures.
Research Focus
Key Achievements
Top Papers
- 1